Delivery Order SPE2DB20D1100-SPE2DB25FE3K8
- Not listed
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of AIRSUPRA 90-80 MCG Inhaler 10.7GM with a ceiling value of $1,315.45. This delivery order is issued under a firm fixed price contract with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a $5,376.82 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for AIRSUPRA 90-80 MCG Inhaler in 10.7GM units, with completion scheduled for August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,328.03 firm fixed price delivery order for AIRSUPRA 90-80 MCG Inhaler 10.7GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Airsupra 90-80 mcg inhalers (10.7 gm units) with a ceiling value of $2,627.78. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. As a child contract, this order draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,894.52 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Airsupra 90-80 micrograms inhaler in 10.7-gram units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,560.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the contractor's corporate office...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3K8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,115.50 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhaler (10.7 gm) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price contract represents a competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is located in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this IDC, the company supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract vehicle enables AmerisourceBergen Drug Corp to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 8/28/25 |